Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Chemo Pharma Laboratories Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Option Chain
Analyzes market sentiment, predicts Chemo Pharma Laboratories Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Chemo Pharma Lab - Disclosure Under Regulation 7(2) Read With Regulation 6(2) - Disclosure Of SEBI (Prohibition Of Insider Tr
-
Chemo Pharma Lab - Disclosure Under Regulation 7(2) Read With Regulation 6(2) - Disclosure Of SEBI (Prohibition Of Insider Tr
-
Chemo Pharma Lab - Intimation Of Appointment Of Secretarial Auditor
-
Chemo Pharma Lab - Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation, 2015
-
Chemo Pharma Lab - Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation, 2015
-
Chemo Pharma Lab has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025
-
Chemo Pharma Lab - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Chemo Pharma Lab - Updates on Open Offer
-
Chemo Pharma Lab - Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2025
-
Chemo Pharma Lab - Board Meeting Outcome for Outcome Of Board Meeting Held On May 29, 2025
-
Chemo Pharma Lab - Updates on Open Offer
-
Chemo Pharma Lab - Intimation With Respect To Opening Of New Corporate Office Of The Company
-
Chemo Pharma Lab - Updates on Open Offer
-
Chemo Pharma Lab - Updates on Open Offer
-
Chemo Pharma Lab - Board Meeting Intimation for Board Meeting To Be Held On Thursday May 29, 2025
-
Chemo Pharma Lab - Letter of Offer
-
Chemo Pharma Lab - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, May 02, 2025
-
Chemo Pharma Lab - Announcement under Regulation 30 (LODR)-Change in Management
-
Chemo Pharma Lab - Announcement under Regulation 30 (LODR)-Change in Management
Key fundamentals
Evaluate the intrinsic value of Chemo Pharma Laboratories Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 13.1446 | 12.8024 | 11.602 | 11.5547 | 10.9947 |
| Liabilities | 13.1446 | 12.8024 | 11.602 | 11.5547 | 10.9947 |
| Equity | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 |
| Gross Profit | -0.1163 | -0.1863 | -0.2088 | -0.405 | -0.3333 |
| Net Profit | 0.3423 | 1.2003 | 0.0473 | 0.5599 | 0.25 |
| Cash From Operating Activities | -0.2824 | 0.7236 | -0.6834 | -0.3285 | 1.5484 |
| NPM(%) | 0 | 0 | 0 | 0 | 0 |
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.1163 | 0.1863 | 0.2088 | 0.405 | 0.3333 |
| ROE(%) | 2.6 | 9.13 | 0.35 | 4.25 | 1.9 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Chemo Pharma Laboratories Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 934.10 | 1.07 | 30.97 | 69.57 | 301.39 | 0.54 |
| Lotus Eye Hospital and Institute Ltd | 76.00 | 2.45 | 215.46 | 253.51 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 22.76 | -0.91 | 0.00 | 526.36 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 896.40 | -1.42 | 0.00 | 239.06 | -601.21 | 0.00 |
Company Info
The Chemo Pharma Laboratories Limited has been an established Company since 1942 and has been making Pharmaceuticals and also had diversified into bulk drugs. However due to increase in competition and flow of new drugs, the Company had to dispose the business and pay all its liabilities and dues. Presently the Company has its own cash resource, with this the Company is proposing to diversify and to take over Sick Company which has excellent future potential. The Company is in advance in the negotiation to some other company and soon rehab to acquire business in Power and Chemicals. 2011 -Registered office of the company has been shifted from Plot no. 5 MIDC, Kalayan -Bhiwandi Road via Kalayan Thane (Maharashtra) to 5, Kumud Apts, CHS Ltd., Karnik Road, Chikan Ghar, Kalyan Dist. Thane-421 301.
The Chemo Pharma Laboratories Limited has been an established Company since 1942 and has been making Pharmaceuticals and also had diversified into bulk drugs. However due to increase in competition and flow of new drugs, the Company had to dispose the business and pay all its liabilities and dues. Presently the Company has its own cash resource, with this the Company is proposing to diversify and to take over Sick Company which has excellent future potential. The Company is in advance in the negotiation to some other company and soon rehab to acquire business in Power and Chemicals. 2011 -Registered office of the company has been shifted from Plot no. 5 MIDC, Kalayan -Bhiwandi Road via Kalayan Thane (Maharashtra) to 5, Kumud Apts, CHS Ltd., Karnik Road, Chikan Ghar, Kalyan Dist. Thane-421 301.
Read More
Parent Organisation
Chemo Pharma Laboratories Ltd.
Founded
17/08/1942
Managing Director
Mr.Bhavin Sheth
NSE Symbol
FAQ
The current price of Chemo Pharma Laboratories Ltd is
The 52-week high for Chemo Pharma Laboratories Ltd is
The market capitalization of Chemo Pharma Laboratories Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Chemo Pharma Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Chemo Pharma Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Chemo Pharma Laboratories Ltd shares.
The CEO of Chemo Pharma Laboratories Ltd is Mr.Bhavin Sheth, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
